112 related articles for article (PubMed ID: 17276927)
1. Role of p21(WAF1) and p27(KIP1) in predicting biochemical recurrence for organ-confined prostate adenocarcinoma.
Wu TT; Wang JS; Jiaan BP; Yu CC; Tsai JY; Lin JT; Huang JK
J Chin Med Assoc; 2007 Jan; 70(1):11-5. PubMed ID: 17276927
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21(waf1/cip1), p27 (kip1), p63 and androgen receptor in low and high Gleason score prostate cancer.
Romics I; Bánfi G; Székely E; Krenács T; Szende B
Pathol Oncol Res; 2008 Sep; 14(3):307-11. PubMed ID: 18415709
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
4. The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.
Wolters T; Vissers KJ; Bangma CH; Schröder FH; van Leenders GJ
BJU Int; 2010 Jul; 106(2):280-6. PubMed ID: 19888978
[TBL] [Abstract][Full Text] [Related]
5. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1/cip1) in the diagnosis of pulmonary neuroendocrine tumours.
Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Lee EH; Roh MS; Seo B
Histopathology; 2012 Apr; 60(5):731-9. PubMed ID: 22296117
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
[TBL] [Abstract][Full Text] [Related]
8. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-related markers for predicting progression of prostate cancer.
Yu DS
J Chin Med Assoc; 2007 Jan; 70(1):3. PubMed ID: 17276925
[No Abstract] [Full Text] [Related]
10. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
Jiang D; Wang X; Liu X; Li F
Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
13. Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression.
Freedland SJ; de Gregorio F; Sacoolidge JC; Elshimali YI; Csathy GS; Elashoff DA; Reiter RE; Aronson WJ
Urology; 2003 Jun; 61(6):1187-92. PubMed ID: 12809895
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
15. Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa).
Sarkar FH; Li Y; Sakr WA; Grignon DJ; Madan SS; Wood DP; Adsay V
Prostate; 1999 Sep; 40(4):256-60. PubMed ID: 10420154
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
[TBL] [Abstract][Full Text] [Related]
17. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.
Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH
J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737
[TBL] [Abstract][Full Text] [Related]
18. [Effects of transfected pIRES-p21(waf1)-p27(kip1) gene on the duplication of centrosomes and the proliferation of breast cancer cell line MCF-7].
Jiang DD; Li FN; Liu XP
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3295-8. PubMed ID: 20193371
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.
Schmider-Ross A; Pirsig O; Gottschalk E; Denkert C; Lichtenegger W; Reles A
J Cancer Res Clin Oncol; 2006 Mar; 132(3):163-70. PubMed ID: 16328436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
